category,datetime,headline,id,image,related,source,summary,url
company,1768477800,BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System,138119892,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BDX,Yahoo,"BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the EnCor EnCompass™ Breast Biopsy and Tissue Removal System, a state-of-the-art multi-modality breast biopsy system designed to provide clinicians with flexibility across breast imaging modalities in the diagnosis of breast disease.",https://finnhub.io/api/news?id=7842d648ac6c543a07c09761a2aa6ad364e9db9177768487a922db21686a2f11
